newsfilter
← Latest News
ACCESS Newswire·

Lexaria to Begin New Human Clinical Study in GLP-1

Contracts signed for Human Pilot Study #7 KELOWNA, BC / ACCESS Newswire / April 1, 2026 / Lexaria Bioscience Corp. , , a global innovator in drug delivery platforms